Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia

MLA

Christoph A. Nienaber, et al. “Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia.” Cardiovascular Drugs and Therapy, vol. 32, Aug. 2018, pp. 353–63. EBSCOhost, https://doi.org/10.1007/s10557-018-6812-z.

APA

Christoph A. Nienaber, Ibrahim Akin, Thomas Bertsch, Linda Reiser, Kambis Mashayekhi, Martin Borggrefe, Muharrem Akin, Uzair Ansari, Christel Weiß, Gabriel Taton, Tobias Schupp, Armin Bollow, Thomas Reichelt, Siegfried Lang, Dominik Ellguth, Michael Behnes, Ibrahim El-Battrawy, & Niko Engelke. (2018). Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia. Cardiovascular Drugs and Therapy, 32, 353–363. https://doi.org/10.1007/s10557-018-6812-z

Chicago

Christoph A. Nienaber, Ibrahim Akin, Thomas Bertsch, Linda Reiser, Kambis Mashayekhi, Martin Borggrefe, Muharrem Akin, et al. 2018. “Beta-Blockers and ACE Inhibitors Are Associated with Improved Survival Secondary to Ventricular Tachyarrhythmia.” Cardiovascular Drugs and Therapy 32 (August): 353–63. doi:10.1007/s10557-018-6812-z.